Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.

Name: Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.
Author: Ammassari, Adriana

Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial. — المؤلف: Ammassari, Adriana — Journal of acquired immune deficiency syndromes (1999) 20191003

المؤلف: Ammassari, Adriana
النشر: Journal of acquired immune deficiency syndromes (1999) 20191003
الوصف: 481-490 p.
الموضوعات: Anti-Retroviral Agents؛ Antiretroviral Therapy, Highly Active؛ HIV Infections؛ Humans؛ Treatment Failure؛ Assessment of Medication Adherence